• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging insights into the molecular and cellular basis of glioblastoma.胶质母细胞瘤的分子和细胞基础的新见解。
Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112.
2
Genomics illuminates a deadly brain cancer.基因组学揭示了一种致命的脑癌。
JAMA. 2010 Mar 10;303(10):925-7. doi: 10.1001/jama.2010.236.
3
Genetics of glioblastoma: a window into its imaging and histopathologic variability.胶质母细胞瘤的遗传学:揭示其影像和组织病理学变异性的窗口。
Radiographics. 2011 Oct;31(6):1717-40. doi: 10.1148/rg.316115512.
4
Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.已确立和新兴的多形性胶质母细胞瘤变异体:形态学和分子特征综述。
Folia Neuropathol. 2012;50(4):301-21. doi: 10.5114/fn.2012.32361.
5
[Classification of glioblastoma and genome profiling].[胶质母细胞瘤的分类与基因组分析]
Neurochirurgie. 2010 Dec;56(6):464-6. doi: 10.1016/j.neuchi.2010.07.009.
6
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.基因表达谱分析揭示了多形性胶质母细胞瘤在分子和临床方面的不同亚型。
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5814-9. doi: 10.1073/pnas.0402870102. Epub 2005 Apr 12.
7
Classification of glioblastoma multiforme in adults by molecular genetics.成人间变性多形性胶质母细胞瘤的分子遗传学分类
Cancer J. 2003 Mar-Apr;9(2):82-90. doi: 10.1097/00130404-200303000-00003.
8
Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.胶质母细胞瘤的分子亚群——通过免疫组化标志物进行评估
Pathol Oncol Res. 2019 Jan;25(1):21-31. doi: 10.1007/s12253-017-0311-6. Epub 2017 Sep 26.
9
Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma.基于转录组谱分析的胶质母细胞瘤预后亚型和多组学特征的鉴定。
Sci Rep. 2019 Jul 22;9(1):10555. doi: 10.1038/s41598-019-47066-y.
10
Genomics boosts brain-cancer work.基因组学推动脑癌研究工作。
Nature. 2010 Jan 21;463(7279):278. doi: 10.1038/463278a.

引用本文的文献

1
High expression of SOX9 is a diagnostic and prognostic indicator of glioma.SOX9的高表达是胶质瘤的诊断和预后指标。
Front Oncol. 2025 Jul 7;15:1531937. doi: 10.3389/fonc.2025.1531937. eCollection 2025.
2
CaMKK2 as a therapeutic target to combat metastasis in glioblastoma.钙调蛋白依赖性蛋白激酶2作为对抗胶质母细胞瘤转移的治疗靶点。
Mol Biol Rep. 2025 Jul 10;52(1):696. doi: 10.1007/s11033-025-10813-8.
3
Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients.癌/睾丸抗原FBXO39和CEP55的表达与胶质母细胞瘤患者的生存情况相关。
PLoS One. 2025 Jun 12;20(6):e0326054. doi: 10.1371/journal.pone.0326054. eCollection 2025.
4
Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance.肿瘤异质性、免疫逃逸和治疗抗性交汇处的胶质母细胞瘤干细胞
Cells. 2025 Apr 9;14(8):562. doi: 10.3390/cells14080562.
5
Multi-transcriptomics reveals niche-specific expression programs and endothelial cells in glioblastoma.多转录组学揭示了胶质母细胞瘤中特定微环境的表达程序和内皮细胞。
J Transl Med. 2025 Apr 15;23(1):444. doi: 10.1186/s12967-025-06185-z.
6
The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis.胶质母细胞瘤患者中HER家族成员、EGFRvIII、假定的癌症干细胞生物标志物CD44和CD109的共表达及细胞定位及其对预后的影响
Cancers (Basel). 2025 Apr 4;17(7):1221. doi: 10.3390/cancers17071221.
7
Inhibition of glioma cell viability by jatrophone via NF-κB down-regulation and apoptosis inhibitor up-regulation.麻风树素通过下调NF-κB和上调凋亡抑制因子来抑制胶质瘤细胞活力。
Arch Med Sci. 2020 Apr 15;21(1):224-232. doi: 10.5114/aoms.2020.94439. eCollection 2025.
8
Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.肿瘤浸润性和循环性B细胞介导胶质母细胞瘤的局部和全身免疫调节机制。
J Neurooncol. 2025 May;172(3):527-548. doi: 10.1007/s11060-025-04989-z. Epub 2025 Mar 13.
9
Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study.动态监测循环肿瘤DNA以预测术后胶质瘤非原位复发风险:一项前瞻性队列研究
Cancer Med. 2025 Mar;14(5):e70733. doi: 10.1002/cam4.70733.
10
Response Assessment in Long-Term Glioblastoma Survivors Using a Multiparametric MRI-Based Prediction Model.使用基于多参数磁共振成像的预测模型对长期胶质母细胞瘤幸存者进行反应评估。
Brain Sci. 2025 Jan 31;15(2):146. doi: 10.3390/brainsci15020146.

本文引用的文献

1
Girdin maintains the stemness of glioblastoma stem cells.Girdin维持胶质母细胞瘤干细胞的干性。
Oncogene. 2017 Jun 29;36(26):3796. doi: 10.1038/onc.2017.17. Epub 2017 Feb 20.
2
IDH mutation impairs histone demethylation and results in a block to cell differentiation.IDH 突变会损害组蛋白去甲基化,导致细胞分化受阻。
Nature. 2012 Feb 15;483(7390):474-8. doi: 10.1038/nature10860.
3
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.(R)-2-羟基戊二酸通过激活 EGLN 发生的转变。
Nature. 2012 Feb 15;483(7390):484-8. doi: 10.1038/nature10898.
4
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.IDH1 突变足以建立起胶质瘤高甲基化表型。
Nature. 2012 Feb 15;483(7390):479-83. doi: 10.1038/nature10866.
5
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.胶质母细胞瘤中受体酪氨酸激酶 EGFR 和 PDGFRA 扩增的瘤内异质性定义了具有不同生长因子反应的亚群。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6. doi: 10.1073/pnas.1114033109. Epub 2012 Feb 8.
6
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.儿童弥漫性内在脑桥神经胶质瘤和非脑干部位神经胶质瘤中的体干细胞组蛋白 H3 改变。
Nat Genet. 2012 Jan 29;44(3):251-3. doi: 10.1038/ng.1102.
7
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.转录共激活因子 TAZ 调节恶性脑胶质瘤中的间充质分化。
Genes Dev. 2011 Dec 15;25(24):2594-609. doi: 10.1101/gad.176800.111.
8
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.通过广泛的肿瘤基因分型鉴定出胆管癌中异柠檬酸脱氢酶 (IDH)1 和 IDH2 的频繁突变。
Oncologist. 2012;17(1):72-9. doi: 10.1634/theoncologist.2011-0386. Epub 2011 Dec 16.
9
An in vivo patient-derived model of endogenous IDH1-mutant glioma.体内源性 IDH1 突变型神经胶质瘤的患者衍生模型。
Neuro Oncol. 2012 Feb;14(2):184-91. doi: 10.1093/neuonc/nor207. Epub 2011 Dec 13.
10
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.鸟苷酸结合蛋白 1 是胶质母细胞瘤中 EGFR 驱动侵袭的新型效应因子。
J Exp Med. 2011 Dec 19;208(13):2657-73. doi: 10.1084/jem.20111102. Epub 2011 Dec 12.

胶质母细胞瘤的分子和细胞基础的新见解。

Emerging insights into the molecular and cellular basis of glioblastoma.

机构信息

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

出版信息

Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112.

DOI:10.1101/gad.187922.112
PMID:22508724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3337451/
Abstract

Glioblastoma is both the most common and lethal primary malignant brain tumor. Extensive multiplatform genomic characterization has provided a higher-resolution picture of the molecular alterations underlying this disease. These studies provide the emerging view that "glioblastoma" represents several histologically similar yet molecularly heterogeneous diseases, which influences taxonomic classification systems, prognosis, and therapeutic decisions.

摘要

胶质母细胞瘤既是最常见的也是最致命的原发性恶性脑肿瘤。广泛的多平台基因组特征分析为这种疾病的分子改变提供了更清晰的图像。这些研究提供了一个新的观点,即“胶质母细胞瘤”代表了几种组织学上相似但分子上不同的疾病,这影响了分类学分类系统、预后和治疗决策。